Related Experiment Video

Updated: Aug 12, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Extended anticoagulation in venous thromboembolism disease. In favour

M C Fernández Capitan1

  • 1Servicio de Medicina Interna, Hospital Universitario La Paz, Madrid, España.

Revista Clinica Espanola
|April 17, 2017
PubMed

Insights

Venous thromboembolism (VTE) is a chronic condition with lifelong recurrence risk. Extended anticoagulation may be considered for first unprovoked VTE after individual risk-benefit assessment.

Area of Science:

  • Cardiology
  • Hematology
  • Internal Medicine

Background:

  • Venous thromboembolism (VTE) poses a lifelong risk of recurrence after the initial event.
  • Discontinuation of anticoagulation therapy leaves patients susceptible to new thrombotic events indefinitely.
  • Current guidelines lack specificity regarding anticoagulation duration for first unprovoked VTE.

Purpose of the Study:

  • To review the evidence supporting extended anticoagulation for patients with venous thromboembolism.
  • To discuss current therapeutic options for managing VTE recurrence risk.
  • To inform clinical decision-making for anticoagulation duration after a first unprovoked VTE episode.

Main Methods:

  • Literature review of studies on VTE recurrence.
  • Analysis of clinical practice guidelines for VTE treatment duration.
  • Evaluation of risk-benefit data for extended anticoagulation therapy.

Main Results:

  • Anticoagulation is effective in preventing recurrence while administered.
  • The risk of thrombotic events persists indefinitely after anticoagulation cessation.
  • Individualized risk-benefit assessment is crucial for treatment decisions in first unprovoked VTE.

Conclusions:

  • Venous thromboembolism management requires careful consideration of long-term recurrence risk.
  • Extended anticoagulation is a viable option for selected patients with first unprovoked VTE.
  • Personalized treatment strategies are essential for optimizing VTE patient outcomes.

Keywords:
Anticoagulación extendidaAnticoagulantesAnticoagulantsEnfermedad tromboembólica venosaExtended anticoagulationHaemorrhageHemorragiaNo provocadoRecurrenceRecurrenciaUnprovokedVenous thromboembolism disease

More Related Videos

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

Synergizing Antegrade Endoscopic with Bridging Vein Harvesting for Improvement of Great Saphenous Vein Graft Quality from the Lower Leg09:04

Synergizing Antegrade Endoscopic with Bridging Vein Harvesting for Improvement of Great Saphenous Vein Graft Quality from the Lower Leg

Published on: November 19, 2019

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...